You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 629-A A safety and feasibility study of the oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Clinical Trial Completed
629-A A safety and feasibility study of the oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer

 

Online download statistics by month:

Online download statistics by month: October 2023 to June 2025

AbstractFullPdf
Oct 2023200
Nov 2023200019
Dec 20236909
Jan 20244200
Feb 20243004
Mar 20243206
Apr 20241204
May 20242202
Jun 20241600
Jul 20242003
Aug 20243006
Sep 20243401
Oct 20241606
Nov 20242207
Dec 20247005
Jan 20252204
Feb 2025805
Mar 2025007
Apr 2025006
May 2025004
Jun 2025004
Total6470102